[Clinical and molecular characteristics of a child with familial adenomatous polyposis].

Juan Zhang,Zailing Li,Xuebiao Huang,Juxiang Ye
DOI: https://doi.org/10.3760/cma.j.issn.0578-1310.2016.03.010
2016-01-01
Abstract:This child with FAP had an early onset of this disease, and clinical conditions were exacerbated with age. Sulindac was partially effective in controlling size and number of polyps. The site of mutation in this case was consistent with classic FAP, and without family history, the mutation may be a sporadic one.
What problem does this paper attempt to address?